Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin Disorders.
Sabbadin C, Beggiao F, Keiko Vedolin C, Orlando G, Ragazzi E, Ceccato F, Barbot M, Bordin L, Donà G, Andrisani A, Belloni Fortina A, Scaroni C, Armanini D. Sabbadin C, et al. Among authors: ceccato f. Endocr Metab Immune Disord Drug Targets. 2023;23(2):188-195. doi: 10.2174/1871530322666220509051746. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 35532249
Predicting late recurrence in surgically treated patients with Cushing's disease.
Barbot M, Albiger N, Koutroumpi S, Ceccato F, Frigo AC, Manara R, Fassina A, Gardiman MP, Scanarini M, Mantero F, Scaroni C. Barbot M, et al. Among authors: ceccato f. Clin Endocrinol (Oxf). 2013 Sep;79(3):394-401. doi: 10.1111/cen.12133. Epub 2013 May 6. Clin Endocrinol (Oxf). 2013. PMID: 23278711
Diagnosis and complications of Cushing's disease: gender-related differences.
Zilio M, Barbot M, Ceccato F, Camozzi V, Bilora F, Casonato A, Frigo AC, Albiger N, Daidone V, Mazzai L, Mantero F, Scaroni C. Zilio M, et al. Among authors: ceccato f. Clin Endocrinol (Oxf). 2014 Mar;80(3):403-10. doi: 10.1111/cen.12299. Epub 2013 Sep 4. Clin Endocrinol (Oxf). 2014. PMID: 23889360
Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentiation.
Occhi G, Regazzo D, Albiger NM, Ceccato F, Ferasin S, Scanarini M, Denaro L, Cosma C, Plebani M, Cassarino MF, Mantovani G, Stalla GK, Pecori Giraldi F, Paez-Pareda M, Scaroni C. Occhi G, et al. Among authors: ceccato f. Endocrinology. 2014 Sep;155(9):3538-49. doi: 10.1210/en.2013-1820. Epub 2014 Jun 13. Endocrinology. 2014. PMID: 24926820
171 results